000 | 02182 a2200637 4500 | ||
---|---|---|---|
005 | 20250514214749.0 | ||
264 | 0 | _c20050330 | |
008 | 200503s 0 0 eng d | ||
022 | _a0007-0920 | ||
024 | 7 |
_a10.1038/sj.bjc.6602355 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDe Placido, S | |
245 | 0 | 0 |
_aA randomised factorial trial of sequential doxorubicin and CMF vs CMF and chemotherapy alone vs chemotherapy followed by goserelin plus tamoxifen as adjuvant treatment of node-positive breast cancer. _h[electronic resource] |
260 |
_bBritish journal of cancer _cFeb 2005 |
||
300 |
_a467-74 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
650 | 0 | 4 | _aChemotherapy, Adjuvant |
650 | 0 | 4 | _aCombined Modality Therapy |
650 | 0 | 4 |
_aCyclophosphamide _xadverse effects |
650 | 0 | 4 | _aDisease-Free Survival |
650 | 0 | 4 |
_aDoxorubicin _xadministration & dosage |
650 | 0 | 4 | _aDrug Administration Schedule |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFluorouracil _xadverse effects |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 |
_aGoserelin _xadministration & dosage |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aLymphatic Metastasis |
650 | 0 | 4 |
_aMethotrexate _xadverse effects |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aTamoxifen _xadministration & dosage |
700 | 1 | _aDe Laurentiis, M | |
700 | 1 | _aDe Lena, M | |
700 | 1 | _aLorusso, V | |
700 | 1 | _aParadiso, A | |
700 | 1 | _aD'Aprile, M | |
700 | 1 | _aPistillucci, G | |
700 | 1 | _aFarris, A | |
700 | 1 | _aSarobba, M G | |
700 | 1 | _aPalazzo, S | |
700 | 1 | _aManzione, L | |
700 | 1 | _aAdamo, V | |
700 | 1 | _aPalmeri, S | |
700 | 1 | _aFerraù, F | |
700 | 1 | _aLauria, R | |
700 | 1 | _aPagliarulo, C | |
700 | 1 | _aPetrella, G | |
700 | 1 | _aLimite, G | |
700 | 1 | _aCostanzo, R | |
700 | 1 | _aBianco, A R | |
773 | 0 |
_tBritish journal of cancer _gvol. 92 _gno. 3 _gp. 467-74 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.bjc.6602355 _zAvailable from publisher's website |
999 |
_c15347152 _d15347152 |